| Literature DB >> 34571277 |
John S Schardt1, Harkamal S Jhajj2, Ryen L O'Meara3, Timon S Lwo2, Matthew D Smith3, Peter M Tessier4.
Abstract
Agonist antibodies that activate cellular signaling have emerged as promising therapeutics for treating myriad pathologies. Unfortunately, the discovery of rare antibodies with the desired agonist functions is a major bottleneck during drug development. Nevertheless, there has been important recent progress in discovering and optimizing agonist antibodies against a variety of therapeutic targets that are activated by diverse signaling mechanisms. Herein, we review emerging high-throughput experimental and computational methods for agonist antibody discovery as well as rational molecular engineering methods for optimizing their agonist activity.Entities:
Keywords: Activation; Agonist; Antibody; Biologic; Discovery; Engineering; Function-based screening; High throughput; mAb; signaling
Mesh:
Substances:
Year: 2021 PMID: 34571277 PMCID: PMC8714685 DOI: 10.1016/j.drudis.2021.09.008
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851